Case report of successful use of VP‐16 in nasopharyngeal carcinoma

Doured Daghistani, Joanna Davis, Stuart Toledano

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


We report the use of VP-16 as a single agent for the treatment of nasopharyngeal carcinoma. Our patient, a 16-year-old Black Haitian male, had complete clinical and radiographic response to VP-16. The remission continued for 14 months. The patient experienced minimal toxicity. We believe that the good response, excellent compliance, and minimal toxicity experienced by our patient should encourage more trials of VP-16 as upfront therapy for patients with nasopharygeal carcinoma.

Original languageEnglish (US)
Pages (from-to)168-169
Number of pages2
JournalMedical and Pediatric Oncology
Issue number2
StatePublished - 1989


  • VP‐16 in NPC
  • compliance
  • remission
  • toxicity

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Cancer Research


Dive into the research topics of 'Case report of successful use of VP‐16 in nasopharyngeal carcinoma'. Together they form a unique fingerprint.

Cite this